Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Contravir Pharmaceuticals, Inc. (CTRV)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Contravir Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Contravir Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is CTRV. The reporting company's CIK number is 1583771.
The total value of stock buying since 2005 is $34,720.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $24,999.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-06-20||Cavan John T (CFO)||Buy||20,000||.65||13,000|
|2016-10-27||Sapirstein James (Chief Executive Officer)||Option Ex||16,666||1.50||24,999|
|2016-02-18||Sapirstein James (Chief Executive Officer)||Buy||10,000||1.00||10,000|
|2015-11-30||Sapirstein James (Chief Executive Officer)||Buy||500||2.15||1,075|
|2015-11-23||Sapirstein James (Chief Executive Officer)||Buy||2,500||1.64||4,100|
|2014-03-04||Brancaccio John P (Director)||Buy||4,393||1.49||6,545|
Insider trading activities including stock purchases, stock sales, and option exercises of CTRV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Contravir Pharmaceuticals, Inc. (symbol CTRV, CIK number 1583771) see the Securities and Exchange Commission (SEC) website.